Sulphamethylisoxazole en es it fr

Sulphamethylisoxazole Brand names, Sulphamethylisoxazole Analogs

Sulphamethylisoxazole Brand Names Mixture

  • Apo Sulfatrim DS Tab (Sulfamethoxazole + Trimethoprim)
  • Apo Sulfatrim Pediatric (Sulfamethoxazole + Trimethoprim)
  • Apo Sulfatrim Tab (Sulfamethoxazole + Trimethoprim)
  • Bactrim DS Roche Tab (Sulfamethoxazole + Trimethoprim)
  • Bactrim Roche Inj (Sulfamethoxazole + Trimethoprim)
  • Bactrim Roche Suspension Paediatric (Sulfamethoxazole + Trimethoprim)
  • Bactrim Roche Tab (Sulfamethoxazole + Trimethoprim)
  • Novo-Trimel DS Tab (Sulfamethoxazole + Trimethoprim)
  • Novo-Trimel Oral Sus (Sulfamethoxazole + Trimethoprim)
  • Novo-Trimel Tab (Sulfamethoxazole + Trimethoprim)
  • Protrin DF Tab (Sulfamethoxazole + Trimethoprim)
  • Protrin Tab (Sulfamethoxazole + Trimethoprim)
  • Riva-Sep DS (Sulfamethoxazole + Trimethoprim)
  • Roubac Tab 160/800 (Sulfamethoxazole + Trimethoprim)
  • Roubac Tab 80/400 (Sulfamethoxazole + Trimethoprim)
  • Septra (Sulfamethoxazole + Trimethoprim)
  • Septra DS Tablets (Sulfamethoxazole + Trimethoprim)
  • Septra Injection (Sulfamethoxazole + Trimethoprim)
  • Septra Pediatric Suspension (Sulfamethoxazole + Trimethoprim)
  • Sulfamethoxazole and Trimethoprim Tablets (Sulfamethoxazole + Trimethoprim)

Sulphamethylisoxazole Chemical_Formula


Sulphamethylisoxazole RX_link

Sulphamethylisoxazole fda sheet

Sulphamethylisoxazole msds (material safety sheet)

Sulphamethylisoxazole MSDS

Sulphamethylisoxazole Synthesis Reference

Kano et al., U.S. Pat. 2,888,455 (1959)

Sulphamethylisoxazole Molecular Weight

253.279 g/mol

Sulphamethylisoxazole Melting Point

167 oC

Sulphamethylisoxazole H2O Solubility

610 mg/L

Sulphamethylisoxazole State


Sulphamethylisoxazole LogP


Sulphamethylisoxazole Dosage Forms


Sulphamethylisoxazole Indication

For the treatment of bronchitis, prostatitis and urinary tract infections.

Sulphamethylisoxazole Pharmacology

Sulfamethoxazole is a sulfonamide drug that inhibits bacterial synthesis of dihydrofolic acid by competing with para-aminobenzoic acid (PABA). Sulfamethoxazole is normally given in combination with Trimethoprim (a dihydrofolate reductase inhibitor). Studies have shown that bacterial resistance develops more slowly with the combination of the two drugs than with either Trimethoprim or Sulfamethoxazole alone.

Sulphamethylisoxazole Absorption

Rapidly absorbed following oral administration.

Sulphamethylisoxazole side effects and Toxicity

No information avaliable

Sulphamethylisoxazole Patient Information

Patients should be instructed to maintain an adequate fluid intake in order to prevent crystalluria and stone formation.

Sulphamethylisoxazole Organisms Affected

Gram negative and gram positive bacteria